Reata Pharmaceuticals, Inc. Net Profit Margin 2016-2023 | RETA
Reata Pharmaceuticals, Inc. net profit margin from 2016 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-06-30 | $0.02B | $-0.09B | -366.67% |
| 2023-03-31 | $0.00B | $-0.36B | -17750.00% |
| 2022-12-31 | $0.00B | $-0.31B | -10433.33% |
| 2022-09-30 | $0.00B | $-0.31B | -7800.00% |
| 2022-06-30 | $0.01B | $-0.31B | -3050.00% |
| 2022-03-31 | $0.01B | $-0.30B | -2763.64% |
| 2021-12-31 | $0.01B | $-0.30B | -2700.00% |
| 2021-09-30 | $0.01B | $-0.28B | -2138.46% |
| 2021-06-30 | $0.01B | $-0.27B | -3871.43% |
| 2021-03-31 | $0.01B | $-0.27B | -3325.00% |
| 2020-12-31 | $0.01B | $-0.25B | -3100.00% |
| 2020-09-30 | $0.01B | $-0.37B | -4612.50% |
| 2020-06-30 | $0.02B | $-0.34B | -2293.33% |
| 2020-03-31 | $0.02B | $-0.31B | -1550.00% |
| 2019-12-31 | $0.03B | $-0.29B | -1074.07% |
| 2019-09-30 | $0.03B | $-0.13B | -403.13% |
| 2019-06-30 | $0.03B | $-0.12B | -413.79% |
| 2019-03-31 | $0.03B | $-0.11B | -393.10% |
| 2018-12-31 | $0.05B | $-0.08B | -152.83% |
| 2018-09-30 | $0.06B | $-0.07B | -130.91% |
| 2018-06-30 | $0.06B | $-0.05B | -84.13% |
| 2018-03-31 | $0.07B | $-0.04B | -54.41% |
| 2017-12-31 | $0.05B | $-0.05B | -97.96% |
| 2017-09-30 | $0.05B | $-0.04B | -67.31% |
| 2017-06-30 | $0.05B | $-0.02B | -46.15% |
| 2017-03-31 | $0.05B | $-0.01B | -25.49% |
| 2016-12-31 | $0.05B | $-0.01B | -12.00% |
| 2016-09-30 | $0.05B | $-0.00B | -8.00% |
| 2016-06-30 | $0.05B | $-0.00B | -4.00% |
| 2016-03-31 | $0.05B | $-0.00B | -6.00% |
| 2015-12-31 | $0.05B | $-0.00B | -3.92% |
